Skip to main content

First Taxotere Bellwether Trial Postponed To September 2019

First Taxotere Bellwether Trial Postponed To September 2019

First Taxotere Bellwether Trial Postponed To September 2019

Introduction

In a case management order issued on March 22, U.S. District Judge Jane Triche Milazzo, presiding over all Taxotere hair loss lawsuits, indicated that the start of the first bellwether trial was delayed until September 16, 2019.

The first five bellwether cases were scheduled to go before the jury on May 13, 2019, and additional cases were scheduled for September 16, 2019; January 27, 2020; May 11, 2020; and September 14, 2020. Taxotere manufacturer Sanofi-Aventis faces some 12,000 product liability claims that it failed to warn about the risks of hair loss from its breast cancer drug, Taxotere, which is not the case with other, equally effective, breast cancer treatments. Though hair loss is a possible side effect of chemotherapy, the lawsuits blamed Sanofi-Aventis of providing misleading information that the patient's hair would regrow after the treatment. However, Taxotere has been reported to cause permanent thinning and balding even long after the treatments are over.

Taxotere lawsuits were centralized in the Eastern District of Louisiana, as part of a federal Multidistrict Litigation, or MDL (MDL No. 2740; In Re: Taxotere (Docetaxel) Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

New Front Emerges in Fight Against Synthetic Opioids

Categories: Opioids

The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…

Exactech to Pay $8M to Settle Defective Knee Implant Suit

Categories: Attune Knee System

Medical device maker Exactech has agreed to an $8 million settlement to resolve allegations that it hid defects in a widely used line of artificial knee implants.

The implants have been linked to thousands of patient injuries and sparked…

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

⏳ Save 20+ Hours Weekly — We’ll Organize Your Medical Records FREE!                     
💼 Delivered in 7 Days. No AI. No Contracts.
Handled by Real Attorneys & Doctors — 100% HIPAA-Compliant.

Only 11 Free Slots remain — Offer Ends Soon!